AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Outcomes and computers: a happy marriage. (outcome management for patients with chemical dependencies)

Addiction & Recovery

| July 01, 1993 | Stout, Chris E. | COPYRIGHT 1993 Vendome Group LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Outcomes management is not just the latest trendy buzzword to be generated by managed care. When conducted well, it yields remarkably important information that can improve clinical efficacy, as well as serve as a remarkable aid in practice/facility management and marketing in a very competitive arena.

It is also true that a central focus in behavioral health care today is on the outcome of chemical dependency treatment services. The ever-increasing demand for more quality and value from treatment, in tandem with fewer health care dollars, creates a marked need for being able to demonstrate clinical efficacy. Outcomes management has tour basic components: 1) patient satisfaction (globally integrated systems thai incorporate a variety of areas, including satisfaction studies of staff, clinicians, referral sources. and payors); 2) treatment outcomes (pre- versus post-treatment measures of symptom reduction from the patient's perspective and from independent measures by the clinician); 3) post-treatment follow-up studies (data collected at various points to monitor treatment efficacy: lack of recidivism/relapse. continued symptom containment or reduction, successful return to work/school. etc.); and 4) methods with which to associate the costs of various treatment methods and outcomes.

To date, treatment efficacy has only been studied in psychotherapeutic interventions; Eysnick's pioneering, yet methodologically flawed, research in the 1950s started the ball rolling. Many subsequent studies, however, have been almost doomed from the start to have limited generalizability or some other shortcoming. Few researchers, and even fewer clinicians, can agree on protocol, methodology, instrumentation, sampling, or statistical analyses for conducting such investigations.

One may then wonder how a practicing clinician, group, or facility may undertake such a study to any beneficial end.

First of all, outcomes management need not be sterile, overly controlled "bench" research. Scientists tend to prefer placebo treatments and control groups, but there is no less "science" in outcomes management. For clinicians, the process is more "micro-science." That is, outcomes management at the facility level does not seek to answer the bigger questions of "What technique is better?" or "Does psychotherapy work?" Instead it provides the facility with specific, ongoing feedback on its efficacy and efficiency of treatment. (Presumably various facilities combining their findings can address the larger questions.)

The clinician may feel a modicum of relief at realizing outcomes management is a "micro-science," yet is typically still concerned about finding the time and money to conduct such research. A growing number of consulting groups and subcontractors provide assistance in everything from structuring to running a system. Depending on volume of practice, program, or facility, such consulting firms may be quite cost-effective.

However, for others, doing-it-yourself may be an option. In undertaking a self-managed outcome research system, the fundamental building blocks are 1 ) a strong methodology that, "fits" in the practice (otherwise one risks "garbage in, garbage out" syndrome); and 2) computerization (literacy a must, fluency preferred). Methodology should include an informed consent form signed upon admission or at a first session. It should meet the Federal standard s for protection of human subjects. (A sample is attached, see Figure 1). Methodological procedures should also be designed to parallel one's standard treatment protocol. This will increase some paperwork, but streamlining makes this an efficient process .

Related articles from newspapers, magazines, journals, and more
New Study Demonstrates Clinical Efficacy of Telithromycin Superior to Standard...
Press release article from: PR Newswire May 24, 2005 700+ words
...randomized clinical superiority trial, showed that the clinical efficacy of telithromycin (marketed as KETEK(R)) in outpatients...investigators in line with local treatment guidelines). Clinical efficacy was assessed by the investigators post-therapy (Day...
SD Pharmaceuticals Completes Pivotal Pre-Clinical Efficacy Study on its Novel...
Press release article from: Business Wire January 11, 2006 700+ words
...SDP) today announced that it has completed a third pre-clinical efficacy study on its novel non-immunogenic formulation of docetaxel...China. "We now have a critical mass of rigorous GLP pre-clinical efficacy and safety data that supports the significant advantage...
High BAb and NAb titers reduce clinical efficacy of IFNbeta in RRMS patients.
Newspaper article from: Biotech Week June 16, 2004 700+ words
...High binding and neutralizing antibody titers reduce the clinical efficacy of IFNbeta in relapsing-remitting MS patients. "We...demonstrate that high titers of both BAbs and NAbs reduce the clinical efficacy of IFNbeta in patients with RRMS, which is important for...
Medtronic's Endeavor(TM) Stent Continues to Show Consistent Clinical Efficacy...
Press release article from: Business Wire March 14, 2006 700+ words
...coronary stent system continues to demonstrate both consistent clinical efficacy and a strong safety profile, according to new data presented...The updated ENDEAVOR III data also showed that safety and clinical efficacy for Endeavor was maintained at 12 months, with no statistically...
Sorin Group: Janus Tacrolimus Eluting Carbostent Demonstrates Excellent Safety...
Press release article from: PR Newswire Europe February 20, 2006 700+ words
...eluting Carbostent provides excellent safety profile and clinical efficacy for the treatment of "real-world" patients, including...from e-Janus support the excellent safety profile and clinical efficacy of the Janus Tacrolimus eluting Carbostent in the treatment...
Clinical Efficacy Data on FACTIVE Tablets for Treatment of Acute Bacterial...
Press release article from: Business Wire October 1, 2004 700+ words
...treatment difference of 0.44%, 95% confidence interval: -6.54 to 7.41). The other study assessed bacteriologic and clinical efficacy and safety of once-daily FACTIVE tablets for five days in patients ages 16 to 81. In this study bacteriologic success...
Infliximab Provides High Clinical Efficacy, Regression of Spinal Inflammation...
Press release article from: PR Newswire October 26, 2002 700+ words
...factor alpha (TNF-alpha) therapy infliximab (also known as REMICADE(R)) can provide a high degree of sustained clinical efficacy for at least one year in patients with active ankylosing spondylitis (AS), a chronic inflammatory rheumatic disease...
TNF-alpha shows high clinical efficacy, regression of spinal...
Newspaper article from: Immunotherapy Weekly November 27, 2002 700+ words
...necrosis factor alpha (TNF-alpha) therapy infliximab (also known as Remicade) can provide a high degree of sustained clinical efficacy for at least 1 year in patients with active ankylosing spondylitis (AS), a chronic inflammatory rheumatic disease...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA